Heike Ilona Rösner

Heike Ilona Rösner

Auto-generated profile, based on publicly available information

Heike Ilona Rösner

Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Molecular Cell
Verified
Journal Article
Open access
KPKonstantinos Paraskevopoulos
Konstantinos Paraskevopoulos
FKFranziska Kriegenburg
Franziska Kriegenburg
MTMichael H. Tatham
Michael H. Tatham
HRHeike I. Rösner
Heike I. Rösner
BMBethan Medina
Bethan Medina
CGColin Gordon
Colin Gordon
The ubiquitin-proteasome system is the major pathway for protein degradation in eukaryotic cells. Proteins to be degraded are conjugated to ubiquitin chains that act as recognition signals for the 26S proteasome. The proteasome subunits Rpn10 and Rpn13 are known to bind ubiquitin, but genetic and biochemical data suggest the existence of at least one other substrate receptor. Here, we show that the phylogenetically conserved proteasome subunit Dss1 (Sem1) binds ubiquitin chains linked by K63 and K48. Atomic resolution data show that Dss1 is disordered and binds ubiquitin by binding sites characterized by acidic and hydrophobic residues. The complementary binding region in ubiquitin is composed of a hydrophobic patch formed by I13, I44, and L69 flanked by two basic regions. Mutations in the ubiquitin-binding site of Dss1 cause growth defects and accumulation of ubiquitylated proteins.

26 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YKYoungho Kwon
Youngho Kwon
HRHeike Rösner
Heike Rösner
WZWeixing Zhao
Weixing Zhao
PSPlaton Selemenakis
Platon Selemenakis
ZHZhuoling He
Zhuoling He
PSPatrick Sung
Patrick Sung
The tumor suppressor BRCA2 participates in DNA double-strand break repair by RAD51-dependent homologous recombination and protects stressed DNA replication forks from nucleolytic attack. We demonstrate that the C-terminal Recombinase Binding (CTRB) region of BRCA2, encoded by gene exon 27, harbors a DNA binding activity. CTRB alone stimulates the DNA strand exchange activity of RAD51 and permits the utilization of RPA-coated ssDNA by RAD51 for strand exchange. Moreover, CTRB functionally synergizes with the Oligonucleotide Binding fold containing DNA binding domain and BRC4 repeat of BRCA2 in RPA-RAD51 exchange on ssDNA. Importantly, we show that the DNA binding and RAD51 interaction attributes of the CTRB are crucial for homologous recombination and protection of replication forks against MRE11-mediated attrition. Our findings shed light on the role of the CTRB region in genome repair, reveal remarkable functional plasticity of BRCA2, and help explain why deletion of Brca2 exon 27 impacts upon embryonic lethality.

5 January 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
DKDitte Kjærsgaard Klein
Ditte Kjærsgaard Klein
SHSaskia Hoffmann
Saskia Hoffmann
JAJohanna K. Ahlskog
Johanna K. Ahlskog
KOKaren O’hanlon
Karen O’hanlon
MQMarianne Quaas
Marianne Quaas
Claus SørensenClaus Sørensen
Claus Sørensen
Cells respond to DNA damage by activating cell cycle checkpoints to delay proliferation and facilitate DNA repair. Here, to uncover new checkpoint regulators, we perform RNA interference screening targeting genes involved in ubiquitylation processes. We show that the F-box protein cyclin F plays an important role in checkpoint control following ionizing radiation. Cyclin F-depleted cells initiate checkpoint signalling after ionizing radiation, but fail to maintain G2 phase arrest and progress into mitosis prematurely. Importantly, cyclin F suppresses the B-Myb-driven transcriptional programme that promotes accumulation of crucial mitosis-promoting proteins. Cyclin F interacts with B-Myb via the cyclin box domain. This interaction is important to suppress cyclin A-mediated phosphorylation of B-Myb, a key step in B-Myb activation. In summary, we uncover a regulatory mechanism linking the F-box protein cyclin F with suppression of the B-Myb/cyclin A pathway to ensure a DNA damage-induced checkpoint response in G2.

29 June 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
RZReihaneh Zarrizi
Reihaneh Zarrizi
MHMartin R. Higgs
Martin R. Higgs
KVKarolin Voßgröne
Karolin Voßgröne
MRMaria Rossing
Maria Rossing
BBBirgitte Bertelsen
Birgitte Bertelsen
Claus SørensenClaus Sørensen
Claus Sørensen
Haploinsufficiency of factors governing genome stability underlies hereditary breast and ovarian cancer. One significant pathway that is disabled as a result is homologous recombination repair (HRR). With the aim of identifying new candidate genes, we examined early-onset breast cancer patients negative for BRCA1 and BRCA2 pathogenic variants. Here, we focused on CtIP (RBBP8 gene), which mediates HRR through the end resection of DNA double-strand breaks (DSBs). Notably, these patients exhibited a number of rare germline RBBP8 variants. Functional analysis revealed that these variants did not affect DNA DSB end resection efficiency. However, expression of a subset of variants led to deleterious nucleolytic degradation of stalled DNA replication forks in a manner similar to that of cells lacking BRCA1 or BRCA2. In contrast to BRCA1 and BRCA2, CtIP deficiency promoted the helicase-driven destabilization of RAD51 nucleofilaments at damaged DNA replication forks. Taken together, our work identifies CtIP as a critical regulator of DNA replication fork integrity, which, when compromised, may predispose to the development of early-onset breast cancer.

20 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Morten GjerstorffMorten Gjerstorff
Morten Gjerstorff
HRHeike I. Rösner
Heike I. Rösner
CPChristina B. Pedersen
Christina B. Pedersen
KGKatrine B. V. Greve
Katrine B. V. Greve
SSSteffen Schmidt
Steffen Schmidt
HDHenrik Ditzel
Henrik Ditzel
GAGE proteins are highly similar, primate-specific molecules with unique primary structure and undefined cellular roles. They are restricted to cells of the germ line in adult healthy individuals, but are broadly expressed in a wide range of cancers. In a yeast two-hybrid screen we identified the metazoan transcriptional regulator, Germ cell-less (GCL), as an interaction partner of GAGE12I. GCL directly binds LEM-domain proteins (LAP2β, emerin, MAN1) at the nuclear envelope, and we found that GAGE proteins were recruited to the nuclear envelope inner membrane by GCL. Based on yeast two-hybrid analysis and pull-down experiments of GCL polypeptides, GCL residues 209–320 (which includes the BACK domain) were deduced sufficient for association with GAGE proteins. GAGE mRNAs and GCL mRNA were demonstrated in human testis and most types of cancers, and at the protein level GAGE members and GCL were co-expressed in cancer cell lines. Structural studies of GAGE proteins revealed no distinct secondary or tertiary structure, suggesting they are intrinsically disordered. Interestingly GAGE proteins formed stable complexes with dsDNA in vitro at physiological concentrations, and GAGE12I bound several different dsDNA fragments, suggesting sequence-nonspecific binding. Dual association of GAGE family members with GCL at the nuclear envelope inner membrane in cells, and with dsDNA in vitro, implicate GAGE proteins in chromatin regulation in germ cells and cancer cells.

13 February 2017 in Biochemistry
Verified
Journal Article
Closed access
HRHeike I. Rösner
Heike I. Rösner
MCMartina Caldarini
Martina Caldarini
APAndreas Prestel
Andreas Prestel
MVMaria Antonietta Vanoni
Maria Antonietta Vanoni
RBRicardo A. Broglia
Ricardo A. Broglia
BKBirthe Kragelund
Birthe Kragelund